Comments
Drugmaker Wockhardt has clocked a 14 per cent growth in its consolidated profit after tax for the three months ended December 31, 2014.
The company registered a profit after tax of ₹347 crore for the quarter under review against ₹304 crore in the corresponding period last year. It clocked revenues of ₹1,382 crore, up 12 per cent from ₹1,237 crore.
Wockhardt’s India business recorded a 15 per cent growth, while its emerging markets business grew 28 per cent in the quarter under review, the company said. And while its UK business grew 141 per cent in pound terms, its US business declined 48 per cent, it added, without giving details.
Wockhardt, at present, faces a ban on some of its products in the US, following regulatory action against some of its India-based plants.
Wockhardt’s shares, however, spiked on the healthy profits reported by the company last quarter, closing up about 9 per cent at ₹1,285 on the BSE on Wednesday.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.